These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35011683)

  • 1. Establishing F1A-CreER
    Hsu YC; Chung YF; Chen MS; Wang CK; Jiang ST; Chiu IM
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression Patterns of Inducible Cre Recombinase Driven by Differential Astrocyte-Specific Promoters in Transgenic Mouse Lines.
    Hu NY; Chen YT; Wang Q; Jie W; Liu YS; You QL; Li ZL; Li XW; Reibel S; Pfrieger FW; Yang JM; Gao TM
    Neurosci Bull; 2020 May; 36(5):530-544. PubMed ID: 31828740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Nkx2-5/CreER transgenic mice for inducible Cre expression in developing hearts.
    Ranjbarvaziri S; Park S; Nguyen NB; Gilmore WB; Zhao P; Ardehali R
    Genesis; 2017 Aug; 55(8):. PubMed ID: 28589709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
    Xu J; Yao G; Ru Y; Xie S
    Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of FGF1B Promoter and FGF1 Are Involved in Cardiogenesis Through the Signaling of PKC, but Not MAPK.
    Lin HY; Lee DC; Wang HD; Chi YH; Chiu IM
    Stem Cells Dev; 2015 Dec; 24(24):2853-63. PubMed ID: 26414172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
    Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
    J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.
    Zhu M; Chen M; Lichtler AC; O'Keefe RJ; Chen D
    Osteoarthritis Cartilage; 2008 Jan; 16(1):129-30. PubMed ID: 17888690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fidelity
    Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
    Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the
    Lesaffer B; Verboven E; Van Huffel L; Moya IM; van Grunsven LA; Leclercq IA; Lemaigre FP; Halder G
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative expression and regulation of duplicated fibroblast growth factor 1 genes in grass carp (Ctenopharyngodon idella).
    Guo DD; Guan WZ; Sun YW; Chen J; Jiang XY; Zou SM
    Gen Comp Endocrinol; 2017 Jan; 240():61-68. PubMed ID: 27677452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a mouse line harboring a Bi-transgene expressing luciferase and tamoxifen-activatable creER(T2) recombinase in cartilage.
    Lo Cascio L; Liu K; Nakamura H; Chu G; Lim NH; Chanalaris A; Saklatvala J; Nagase H; Bou-Gharios G
    Genesis; 2014 Feb; 52(2):110-9. PubMed ID: 24339176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines.
    Sun MY; Yetman MJ; Lee TC; Chen Y; Jankowsky JL
    J Comp Neurol; 2014 Apr; 522(5):1191-208. PubMed ID: 24519019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally controlled somatic mutagenesis in smooth muscle.
    Kühbandner S; Brummer S; Metzger D; Chambon P; Hofmann F; Feil R
    Genesis; 2000 Sep; 28(1):15-22. PubMed ID: 11020712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines.
    Stone JS; Wisner SR; Bucks SA; Mellado Lagarde MM; Cox BC
    J Assoc Res Otolaryngol; 2018 Aug; 19(4):381-399. PubMed ID: 29869046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
    Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S
    Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Rovira M; Maestro MA; Grau V; Ferrer J
    Islets; 2021 Sep; 13(5-6):134-139. PubMed ID: 34282714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.